Company intelligence / Profile preview

Phospholutions

State College, Pennsylvania, United Statesphospholutions.com ↗

Ownership: Private
Development stage: Commercial

Overview

Phospholutions has developed and commercialized the RhizoSorb® platform, which increases phosphorus fertilizer efficiency, reduces environmental impact (notably reducing runoff by up to 58% and carbon emissions by over 45% compared to conventional fertilizers), and enables growers to reduce phosphorus use by up to 50% while maintaining yields. The first full-scale production run was completed in early 2024, with ongoing product performance trials in major crops such as corn and wheat[1][2][3][4][8].

Industry: Agriculture & AgTech

Drug pipeline

1 asset

RhizoSorb 8-39-0

Commercial

Indications: Agricultural fertilizer

Partnerships

Toros Agri (commercial-scale production partner for Europe)

Beyond the preview

Go deeper on Phospholutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phospholutions.

Explore the full profile